$BMY tops off CAR T patent win over $GILD as award swells to $1.2B; today's roundup also includes approval for Braftovi plus Erbitux, and news from Merck, Liquidia, Circassia-AZ, and Korea's Bridge $MRK $BMY $LQDA $GILD https://t.co/dZeBhpa9sj